Melanoma FRCR CO2A Flashcards

1
Q

origin of melanocytes and its migration

A

neural crest and migrates to basal layer of the epidermis and the uveal tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of cutaneous melanoma

A
  1. superficial spreading
  2. nodular
  3. acral lentiginous
  4. lentigo maligna melanoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Reason for rise in MM

A
  1. increased detection
  2. excessive recreational exposure to sunlight
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

peak incidence and commonly affected race

A

4th and 5th decade

white>non white (10 x)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

RFs for Melanoma

A
  1. UV rad exp’
  2. skin type: fair skin with blond or red hair
  3. no of common naevi
  4. family hx
  5. CDKN2A : inherited germline mutation
    6 . PUVA treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Protective Role

A

Vitamin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Prevention strategies

A
  1. spend time in the shade between 11 am to 3 pm
  2. avoid getting sunburnt
  3. cover up with a hat, t shirt and sunglasses
  4. take extra care with sun protection for children
  5. SPF 15 sunscreen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pathology of mlenoma

A

atypical melanocytes that infiltrates into the dermis

no of mitoses, LVSI and regression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

feature of superficial spreading melanoma

A
  1. 70%
  2. pigmented lesions often flat or with slight elevation, irregular border and irregular pigmentation
  3. micro: dominant horizontal growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nodular melanoma features:

A
  1. 15% of cases
  2. raised, nodular lesion, blue - grey to completely amelanocytic
  3. a/w ulceration / bleeding
  4. micro : no or minimal horizontal growth but ext dermal invasion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acral lentiginous melanoma features?

A
  1. 10 % of cases
  2. palms, soles, subungual regions (great toe, thumb)
  3. less related to UV exp
  4. micro: acanthosis of epidermis, atypical melanocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

lenti maligna melanoma (LMM)

A

5%

older pts usually on face

chronic sun exposure

precursor lesion: Hutchinson’s freckle, 5 % progress to LMM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Breslow thickness

A

measures the depth of a melanoma tumor from the surface of the skin to the deepest point of the tumor cells, and is measured in millimeters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Breslow thickness staging

A

Tis: Melanoma cells are only in the very top layer of the skin (epidermis).

T1: Melanoma is 1mm thick or less.

T2: Melanoma is between 1mm and 2mm thick.

T3: Melanoma is between 2mm and 4mm thick.

T4: Melanoma is more than 4mm thick.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

spread of Melanoma

A

skin, subcut tissues and LNs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

local spread of melanoma

A

initially, horizontal growth f/b vertical growth through dermis

17
Q

Satellite nodules and in transit nodules

A

satellites nodules: cut or subcut nodules less than 2 cm from primary tumor

in transit nodules: beyond 2 cm but not beyond the draining LNs

18
Q

metastatic spread of melanoma

A

Lung
Liver Bone
Brain

small bowel
meninges
GB
adrenals

19
Q

main c/f of cut melanoma

A

pigmented lesion with an irregular edge and irregular pigmentation

20
Q

ABCDE rule for melanoma

A

examination rule

A: Asymmetry
B: Boder irregular
C: Color irregular
D: Diameter > 5 mm
E: Elevation

21
Q

Revised 7 point check list

A

Major Features:
1. change in size of lesion
2. irregular pigmentation
3. irregular border

Minor features
1. inflammation
2. largest diameter 7 mm or greater
3. OOzing crusting or bleeding

22
Q

D/D of melanoma

A
  1. basal cell papilloma
  2. pigmented BCC
  3. thrombosed angioma
  4. pyogenic granuloma
  5. Dermatofibroma
23
Q

Investigations and Staging of melanoma

A
  1. Dermatoscopy:
  2. excision of the lesion s/times incisional
  3. C/E of LNs
24
Q

margin requirement as per lesion size

A

< 1 mm: 1 cm
1 - 2 mm: 1-2 cm
2 - 4 cm : 2 - 3 cm
> 4 cm : 3 cm

25
Surgery for localized cut melanoma
Wide excision of primary lesion, margin depends on breslow thickness
26
Elective Lymph Nodal Dissection (ELND)
in presence of SLNB positive
27
when is therapeutic complete node dissection advised in melanoma
clinically palpable nodal disease
28
current UK practise for SLNB
Melanoma > 1 mm
29
Stage IA adjuvant Rx
observation
30
Stage IB Adjuvant Rx
depends on SLN report, if negative observation if +, further work up
31
stage Ib or II
adjuvant Pembrolizumab (category 1) * Nivolumab (category 1)
32
stage IIIA/IIIB/IIIC adjuvant treatment
Nivolumab Pembrolizumab Dabrafenib/ trametinib if BRAF V600 mutation positive
33
stage wise 5 yr OS
I: 91 % II: 64 % III: 40 %
34
Prognostic factors at time of presentation:
1. Tumor Thickness 2. Ulceration 3. LNs 4. gender (female better than males) 5. Anatomical location (extremities better than face) 6. Age
35
Role of RT in melanoma
SRT/SRS for brain mets
36
metastatic melanoma Rx
Nivolumab/ipilimumab (category 1) Nivolumab and relatlimab (category 1) * Anti-PD-1 monotherapyd,f,g Pembrolizumab (category 1) Nivolumab (category 1) Other recommended regimens * Combination targeted therapy if BRAF V600 mutation positive Dabrafenib/trametinib (category 1) Vemurafenib/cobimetinib (category 1) Encorafenib/binimetinib (category 1) * Pembrolizumab/low-dose ipilimumabo (category 2B)